Pricing Log in Create free account

Aditxt, Inc. (ADTX) vs Enlivex Ltd. (ENLV)

Aditxt, Inc. and Enlivex Ltd. are both Biotechnology companies. Aditxt, Inc. and Enlivex Ltd. are of similar size ($4.5M and $4.4M). Aditxt, Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Enlivex Ltd. has the higher net margin (0.00% vs −372,998.6%) and the lower return on invested capital (−5.85% vs 0.00%). Across the 13 metrics below, Enlivex Ltd. leads on 7 and Aditxt, Inc. on 6.

Valuation

Metric ADTX ENLV Biotechnology median
P/E n/m 0.00 8.50
P/S n/m n/m 9.71
P/B n/m 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 240.66 0.64
EV/Sales 73.26 n/m 9.21
Earnings yield 0.00% 248,526.43% (33.15%)
Free cash flow yield 0.00% (301.79%) (25.50%)

Profitability

Metric ADTX ENLV Biotechnology median
Gross margin 20.28% 0.00% 65.16%
Operating margin (128,143.36%) 0.00% 0.00%
Net margin (372,998.60%) 0.00% 0.00%
Free cash flow margin (129,979.72%) 0.00% 0.00%
Return on equity 549.59% 159.77% (56.36%)
Return on assets (236.38%) 127.16% (48.04%)
Return on invested capital 0.00% (5.85%) 0.00%

Growth

Metric ADTX ENLV Biotechnology median
Revenue growth (TTM) (74.19%) — 6.02%
EPS growth (last fiscal year) (918.27%) 3,590.26% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADTX ENLV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.06 119.39 4.72
Net debt to EBITDA 0.18 118.29 0.96

Dividend

Metric ADTX ENLV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ADTX ENLV Biotechnology median
Market cap 4.39m 4.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack